Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02630017 · ClinicalTrials.gov registry record · Phase 2
Motivated Behavior in Adults With and Without ADHD
A Phase 2 study, sponsored by University of Arkansas.
- Completed
- Registry status
- Phase 2
- Development phase
- 51
- Enrollment target
NCT02630017 is a Phase 2 study that has completed, run by University of Arkansas. The registered enrollment target is 51 participants.
The verdict
NCT02630017, a Phase 2 study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 51 participants
- Enrollment target
Study Summary
To investigate the effects of methylphenidate on motivated behavior in adults with and without ADHD
Interventions
- DRUG ADHD methylphenidate first, placebo second
- DRUG ADHD placebo first, methylphenidate second
- DRUG Non-ADHD methylphenidate first, placebo second
- DRUG Non-ADHD placebo first, methylphenidate second
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2016-03-07 |
| Est. Completion | 2018-09-21 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02630017
The ClinicalTrials.gov registry entry for NCT02630017 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which ADHD methylphenidate first, placebo second is the first listed.
NCT02630017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02630017 about?
NCT02630017 is a clinical study titled "Motivated Behavior in Adults With and Without ADHD". To investigate the effects of methylphenidate on motivated behavior in adults with and without ADHD
What is the current status of trial NCT02630017?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 51 participants. The study started on 2016-03-07. Estimated completion is 2018-09-21.
What interventions are being tested in trial NCT02630017?
The interventions under investigation include: ADHD methylphenidate first, placebo second (DRUG), ADHD placebo first, methylphenidate second (DRUG), Non-ADHD methylphenidate first, placebo second (DRUG), Non-ADHD placebo first, methylphenidate second (DRUG).
Who is sponsoring clinical trial NCT02630017?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.